PharmEvo
CompanyPakistan
PharmEvo develops one asset, in phase 3 (BPM31510 in Parkinson's disease). Mostly supplement; based in Pakistan.
- 1
- Asset
- Furthest stage
- Phase 3
- 4
- Trials
- 0
- Signals
Pipeline
1Supports mitochondrial electron transport and antioxidant defenses.
Phase 3, Supplement, Parkinson's disease, glioblastoma (Phase 2)
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials6
- Signals4
- Similar companies6